Pfizer expects revenue to drop by at least 30% in 2023
Before the U.S. stock market opened on Tuesday, January 31, the U.S. pharmaceutical giant Pfizer announced its fourth quarter and full-year results for 2022, and announced its 2023 performance guidance. In 2022, Pfizer’s revenue will reach a record US$100.3 billion, nearly six of which will be contributed by new crown vaccines and drugs. As the […]
Pfizer expects revenue to drop by at least 30% in 2023 Read More »